EMD 1.96% 5.2¢ emyria limited

EMD Research, page-30

  1. 201 Posts.
    lightbulb Created with Sketch. 84
    After the recent announcements from BOT, ZLD and EMD, do you agree that
    1- BOT is a step closer after good phase 2 results, is the next step for BOT is to find a big pharma to fund phase 3 then BOT becomes the next GW ?

    2- after reporting low sales, is ZLD’s shortcut model not the way to go but rather RWD or trials ?

    3- for EMD, can their RWD take them directly to a TGA/ FDA approval or they still need to do phase 2 and 3 ?

    many thanks for your informative answers
 
watchlist Created with Sketch. Add EMD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.